Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells
Cell · 2026
DOI: 10.1016/j.cell.2025.12.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2026. Verfasst von Emanuel Salazar-Cavazos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunodynamics Group, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, Fondation ARC pour la Recherche sur Le Cancer.
Abstract (Originalsprache)
Cancer immunotherapies trigger highly variable responses in patients and in genetically identical mouse models. To assess the intrinsic stochasticity of these therapies, we performed thousands of well-controlled ex vivo immunoassays. We show that leukocyte responses and tumor cytotoxicity are highly variable at the macroscopic level and statistically distributed as a shifted Poisson process. Stochastic activation of a rare subpopulation of T cells (so-called Spark T cells), coupled with a paracrine interferon (IFN)-γ-driven positive feedback, accounts for this measured "noise" in immunotherapeutic reactions. We integrated these quantitative insights into a custom-designed machine-learning pipeline to analyze immune reactions with single-cell resolution. This led us to phenotypically and functionally identify Spark T cells in murine naive T cells and in human T cell blasts as prepared for adoptive T cell therapy. We then demonstrate their relevance in explaining variable outcomes in cancer immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunodynamics Group, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Inserm U1330 and Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France; Inserm U932, Institut Curie, PSL Research University, 75005 Paris, France.
- Immunodynamics Group, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheuma…
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Förderung
- Intramural NIH HHS
- National Institutes of Health
- Fondation ARC pour la Recherche sur Le Cancer
- NIH National Cancer Institute
- INSERM
Zitieren
APA
Salazar-Cavazos, E., Jia, D., Missolo-Koussou, Y., Kenet, A. L., Achar, S. R., Dada, H., Kondo, T., Krishnan, A., Taylor, N., Klemen, N. D., Jiang, P., Waterfall, J. J., DeVoe, D. L., & Altan-Bonnet, G. (2026). Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells. Cell. https://doi.org/10.1016/j.cell.2025.12.026
Vancouver
Salazar-Cavazos E, Jia D, Missolo-Koussou Y, Kenet AL, Achar SR, Dada H, et al. Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells. Cell. 2026. doi:10.1016/j.cell.2025.12.026
BibTeX
@article{SalazarCavazos2026,
author = {Salazar-Cavazos, Emanuel and Jia, Dongya and Missolo-Koussou, Yoann and Kenet, Adam L and Achar, Sooraj R and Dada, Hannah and Kondo, Taisuke and Krishnan, Anagha and Taylor, Naomi and Klemen, Nicholas D and Jiang, Peng and Waterfall, Joshua J and DeVoe, Don L and Altan-Bonnet, Grégoire},
title = {Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells},
journal = {Cell},
year = {2026},
doi = {10.1016/j.cell.2025.12.026}
}
EUVIMED